chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pronounced arm pain within two hours then inability to raise arm above shoulder after 3 hours, then weak feeling, fever at 103 and severe fatigue and sleepiness and headache.
Pt vaccinated with DTP/OPV experiencing vomitting to dry heaves, redness at inject site.
9PM hives, rash, screaming episode;temp unk;sz lasting 15-20min in route to ER;adm to hosp 945Pm-sz x 2;8min tonic sz followed by postictal phase then 2 more clonic gen sz activity 45-50sec;
After 15 minutes of administration, pt is saying that he has "tightness around his heart" but no difficulty breathing. After 5 more minutes, but then, he said he feels chest tightness on his right side.  He got his shot on his right arm.  I told him it is probably not an allergic rxn since he has no swelling/rash, no problem with breathing.  Most likely he is feeling something on his right side because he got the shot on his right arm.
administered expired vaccine to patients, after the manufacture date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered expired vaccine to patients, after the manufacture date of expiration) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered expired vaccine to patients, after the manufacture date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered expired vaccine to patients, after the manufacture date of expiration) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant and treatment medication was not reported. Number of doses administered was 102 doses. The vial did not undergo any temperature excursions.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow up contains non significant information
Fever, rash, pruritus - Information has been received from a registered nurse concerning a 16 month old East Indian male patient with hypotonia since birth and poor suck and swallow reflex who on 03 Jul 2000 was vaccinated in the left buttock with a first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation ) (lot #633095 /0254K).  It was noted that the patient was diagnosed with left otitis media at the time of vaccination and was placed on therapy with amoxicillin.  On 12 July 2000 the patient experienced a high fever of 102-103 Fahrenheit and a generalized itchy rash.  The patient was advised to give her son a fever reducer and a lukewarm bath.  If the fever peraisted she was to bring the baby into the office.  On 15 Jul 2000 the patient recovered.  Two additional patient (Wases # 000713119) had a similar experience.  The reporter expressed a concern with the lot number.  No further information is available.
This spontaneous report as received from a pharmacist refers to a 22 year old, non-pregnant, female patient. On 04-JUN-2014 the patient was vaccinated with VARIVAX (Merck) (lot number reported as K001364) (dose and route were not reported). Concomitant medications were not reported. On 04-JUN-2014, the patient became white as a sheet and fainted for about 20 seconds, after receiving VARIVAX (Merck)." The pharmacist observed the patient for 25 minutes after she came to and the patient left the pharmacy on her own. Patient did not seek medical attention. The outcome of became white like a sheet was not reported. The outcome of fainted for about 20 seconds was recovered/resolved. The relationship between VARIVAX (Merck) and the events was not reported. Additional information has been requested.
Within 3 hours of shot I had achy body like flu symptoms; Within 3 hours of shot I had achy body like flu symptoms; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Within 3 hours of shot I had achy body like flu symptoms) and INFLUENZA (Within 3 hours of shot I had achy body like flu symptoms) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included AMLODIPINE and TIMOLOL for an unknown indication.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced PAIN (Within 3 hours of shot I had achy body like flu symptoms) and INFLUENZA (Within 3 hours of shot I had achy body like flu symptoms). At the time of the report, PAIN (Within 3 hours of shot I had achy body like flu symptoms) and INFLUENZA (Within 3 hours of shot I had achy body like flu symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.     No treatment information was provided.
Excruciating pain in left shoulder; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Excruciating pain in left shoulder) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Excruciating pain in left shoulder). At the time of the report, ARTHRALGIA (Excruciating pain in left shoulder) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Itchiness throughout body, swollen shots on wrists and under feet, tiny dots on arms  Now resolved
Patient developed a large pulmonary embolism with right-sided heart strain.  COVID is negative.
Tighten and sore at injection site. Arm pain when raising shoulder. Fever of 101 and chills about 24 hours after injection. Lasted for 8 hours after use of Tylenol and ibuprofen. Arm pain remains after 48 hours.
Raised cirular areas to trunk, legs and arms. Haring from 5mm ti 35-40mm at widest point. Reports some areas to face also, clearing, post Benadryl applied per father no continues itch at present. Child had Immunization prior without reaction.
she was "dead" "all day" / she could not even move; she was "dead" "all day" / she could not even move; her arm at the injection site was painful; headache; tired; muscle pain; chills; just "wasn't feeling great at all."; This is a spontaneous report from a contactable nurse (patient). A 37-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot number was not reported), via an unspecified route of administration on 17Apr2021 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient reported that she received her first dose of the Pfizer BioNTech COVID-19 vaccine on Saturday (17Apr2021) and experienced some side effects. She stated that on Saturday she felt fine, but on Sunday (18Apr2021), her arm at the injection site was painful. On Monday (19Apr2021), she was dead all day and reported that she could not even move. She also experienced headache, tired, muscle pain, chills, and just wasn't feeling great at all on an unspecified date in Apr2021. She stated that today she was feeling better. The outcome of the events was recovering.  Information on the batch/lot number has been requested.
Cold; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Cold) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (Cold). At the time of the report, NASOPHARYNGITIS (Cold) outcome was unknown.            No concomitant medications were provided by the reporter.   Patient experienced cold on an unspecified day of August. Treatment information was not provided.
Medical Assistant gave the patient Gardasil 9 instead of Prevnar 13. No symptoms but mom has been informed.
First, I would like to state that prior to vaccination, I did not have any left shoulder pain or injuries. I was given the flu shot into my left shoulder by the pharmacist. It was given too high on the shoulder. It was administered approximately 2cm below the acromion. I began to have pain and stiffness within one hour of the injection. When the symptoms continued to get worse, I went to the urgent care two days after vaccination, and despite requesting a steroid, I was given Meloxicam and sent home. When the pain continued to persist and get worse, I went to see my primary physician on November 13, 2013. She prescribed prednisone. It worked while I was taking it, but once I discontinued it, the symptoms returned soon after. I saw a pain management physician on December 9th, who ordered an MRI. The MRI was performed on December 11, 2013. This showed bursitis and tendonitis of the left shoulder. He ordered physical therapy, which I did in January 2014. I then began seeing an orthopedic surgeon on February 21, 2014. He ordered more physical therapy. When that wasn't helping, he gave me a steroid shot into the left shoulder. We proceeded with more physical therapy. When that still was not helping, we opted for surgery. I had a subacromial decompression and biceps tendonesis on June 10, 2014. I began more physical therapy after surgery. The pain continued to persist. He gave me another steroid injection into the left shoulder on October 3, 2014. The symptoms have continued through all of this treatment. The orthopedic surgeon recommended in November 2014 that I get a second opinion. I am currently doing this and have a new orthopedic surgeon who has ordered an arthrogram MRI of my left shoulder because he believes there may be more damage in the shoulder.
Moderna COVID-19 Vaccine EUA No tenderness or swelling of the injection site on the day of.  When I woke up the next morning, there was a large lump and redness at the site, as well as Tenderness. The swelling  dispersed as the day went on, and right now the whole upper half of my right upper arm is swollen. There is about a 2 inch spot of resness right at the site of injection. The tenderness has increased to the point of affecting daily activities and sleep. No other reactions to report.
Dull achey pain in center of chest and between shoulder blades. Consistent pain that did not change upon rest or exertion but left with all other vaccine symptoms of fatigue and chills within 24 hours. No difficulty breathing.
Narrative: COVID infection following completion of COVID vaccine series 01/12/21 COVID vaccine dose #1 02/02/21 COVID vaccine dose #2 07/14/21 Pt presents to clini c complaining of dysphagia, hoarseness, and increased mucus along with problems with liquids and solid: swallow test ordered and rx given for amoxicillin and DM/guaifenesin 08/01/21 Pt presents to screening reporting muscle pain, runny nose: temp 97.9; COVID POSITIVE 08/02/21 Pt reports chills x3 days, cough x4-5 days, mild headache, muscle pain (baseline), runny nose, shortness of breath (baseline), sore throat; rx given for cholecalciferol; DM/guaifenesin, fluticasone, throat lozenges 08/03/21 Pt reports productive cough, chronic fatigue, muscle pain, mild shortness of breath, sore throat 08/06/21 Pt reports loss of taste/smell, sore throat, and cough 08/07/21 Pt reports diarrhea upon coughing; denies blood in stool or abdominal pain 08/09/21 Pt reports dry cough that is improving rx given for benzonatate; clinically resolved
diarrhea; severe chills, could not get warm; hurt to walk; body aches; fever; headaches; hot burning sensation at the site of injection; was in bed all day; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot burning sensation at the site of injection), DIARRHOEA (diarrhea), CHILLS (severe chills, could not get warm), GAIT DISTURBANCE (hurt to walk) and PYREXIA (fever) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in October 2020.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot burning sensation at the site of injection), CHILLS (severe chills, could not get warm), GAIT DISTURBANCE (hurt to walk), PYREXIA (fever) and HEADACHE (headaches). On 21-Jan-2021, the patient experienced DIARRHOEA (diarrhea). On 20-Jan-2021, VACCINATION SITE WARMTH (hot burning sensation at the site of injection) had resolved. On 21-Jan-2021, DIARRHOEA (diarrhea), GAIT DISTURBANCE (hurt to walk) and PYREXIA (fever) had resolved, CHILLS (severe chills, could not get warm) outcome was unknown. At the time of the report, HEADACHE (headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient used Tylenol as treatment.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jan-2021: No specific follow-up information recorded.
Severe headache, chills, fever, chest pain, body aches.  Slept over 16 hours waking only to drink.  Symptoms lasted for 18 hours.
c/o itching in mouth and throat. Flushing noted in face. Benadryl 50 mg IM given in Right deltoid at 1002. Now 1026 with no progression and no improvement MOVE team called
7 cm in diameter - erythematous (ear with local nodule (2 cm in diameter).
Vertigo, fever, chills, severe headache, stuffy sinuses, fatigue, heart palpitations
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 77-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 27Oct2022 at 15:30 as dose 5 (booster), single (Lot number: Gj5342) at the age of 76 years, in right arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Sep2023, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Sep2023) Positive, notes: COVID 19 Treatment. Therapeutic measures as Paxlovid were taken as a result of drug ineffective, covid-19 from 22Sep2023 to 26Sep2023.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300315968 Same reporter/patient, different drug, different event.;
Fever; Headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 28-Apr-2021 and was forwarded to Moderna on 28-Apr-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Apr-2021, the patient experienced PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Caller was calling in behalf of his father, who cannot speak English, who received the first dose of the Moderna COVID-19 vaccine a week ago. His father experienced fever and headache that started two or three days ago, and he still experiencing it at the time of the call. He wanted to know if he should bring his father to a clinic or doctor.Unable to gather adverse event details, contact information, consent, and vaccine details as caller was in a hurry to seek medical treatment for his father. There is no concomitant list   Reporter did not allow further contact
Tightness in chest Severe and debilitating muscle pain  Fever Joint pain and stiffness
sore arm, headache, tired, stomach cramps, diarrhea-2 days, has subsided
Oxygen level was dropping; Slight cough; He was very sleepy.; COVID-19 virus test positive; could not finish his sentences; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of OXYGEN SATURATION DECREASED (Oxygen level was dropping), COUGH (Slight cough) and SOMNOLENCE (He was very sleepy.) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Immunodeficiency (Common variable immune deficiency - Some doctors says he has it, some doctors says he does not have it.), Prostate cancer and COPD.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced OXYGEN SATURATION DECREASED (Oxygen level was dropping) (seriousness criterion hospitalization), COUGH (Slight cough) (seriousness criterion hospitalization), SOMNOLENCE (He was very sleepy.) (seriousness criterion hospitalization), SARS-COV-2 TEST POSITIVE (COVID-19 virus test positive) and SPEECH DISORDER (could not finish his sentences). The patient was hospitalized on 15-Apr-2021 due to COUGH, OXYGEN SATURATION DECREASED and SOMNOLENCE. At the time of the report, OXYGEN SATURATION DECREASED (Oxygen level was dropping), COUGH (Slight cough), SOMNOLENCE (He was very sleepy.), SARS-COV-2 TEST POSITIVE (COVID-19 virus test positive) and SPEECH DISORDER (could not finish his sentences) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, SARS-CoV-2 antibody test: positive (Positive) Positive and. On 15-Apr-2021, SARS-CoV-2 antibody test positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment was reported.  On 15 Apr 2021, the patient developed a slight cough, had difficulty finishing his sentences, the patient's oxygen levels had dropped and was sleepy. The patient was admitted to the hospital and tested twice for COVID-19, both times were positive.  Company comment:Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded except for the event of SARS-CoV-2 test positive which is unlikely.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded except for the event of SARS-CoV-2 test positive which is unlikely.
Just Sore arm and a bad Headache for 2 days.  Sending just for information value on the vaccine.  Just took tylenol on next day.
Ten days after receiving Moderna booster #1, the patient experienced sudden total loss of hearing in his left ear. He has been to his PCP and to a specialist. The issue did not resolve. As of today, 4/20/22, he still has no hearing in the left ear.
Daughter is on birth control, and finished her cycle 2 weeks a ago and has started again today. She?s been on birth control for a year and has been regular since.  I will be calling her gynecologist today.
Swelling and pain in neck-surrounding adams apple area, thyroid. feels like it's the muscle causing pain not internal sorethroat  Narrative:
extreme pain in her arm pit; her lymph nodes on the left side of her body were swollen from her neck to her groin; tingling in her left arms; numbness in her left arm; unable to grip her left hand or able to hold anything; low grade fever of 99.4F; inflammation; soreness at injection; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE INFLAMMATION (inflammation), VACCINATION SITE PAIN (soreness at injection), AXILLARY PAIN (extreme pain in her arm pit), PARAESTHESIA (tingling in her left arms) and HYPOAESTHESIA (numbness in her left arm) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 08-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE INFLAMMATION (inflammation) and VACCINATION SITE PAIN (soreness at injection). On 13-Jan-2021, the patient experienced AXILLARY PAIN (extreme pain in her arm pit), PARAESTHESIA (tingling in her left arms), HYPOAESTHESIA (numbness in her left arm), GRIP STRENGTH DECREASED (unable to grip her left hand or able to hold anything) and PYREXIA (low grade fever of 99.4F). The patient was treated with IBUPROFEN at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE INFLAMMATION (inflammation), VACCINATION SITE PAIN (soreness at injection), AXILLARY PAIN (extreme pain in her arm pit), PARAESTHESIA (tingling in her left arms), HYPOAESTHESIA (numbness in her left arm), GRIP STRENGTH DECREASED (unable to grip her left hand or able to hold anything) and PYREXIA (low grade fever of 99.4F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Jan-2021, Body temperature: 99.4f (Low) low grade fever of 99.4F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant medications were not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
This spontaneous report as received from a Licensed Practical Nurse refers to a patient of unknown age and unknown gender. No pertinent medical history and drug reactions/allergies were reported. On 25-MAR-2016, the patient was inadvertently vaccinated with an expired dose of ZOSTAVAX (strength, dose and frequency were not reported) (lot # L029480, expiry date: 16-MAR-2016). No adverse effects reported. No product quality complaint (PQC) was involved. Additional information has been requested.